Envoy Medical COCH Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
- Envoy Medical (COCH) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount of -$200K in Q4 2025.
- How has Envoy Medical's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount changed year-over-year?
- Envoy Medical's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount increased by 69.1% year-over-year, from -$646.25K to -$200K.
- What is the long-term trend for Envoy Medical's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount?
- Over 3 years (2022 to 2025), Envoy Medical's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount has grown at a 10.1% compound annual growth rate (CAGR), from $600K to -$800K.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount mean?
- The net change in the valuation allowance established against deferred tax assets during the reporting period. An increase in the allowance suggests management's reduced confidence in realizing future tax benefits. This reflects the company's assessment of future taxable income generation.